Zohar Shlomo 4

What Happened
Zohar Shlomo, a director of Delek US Holdings, sold a total of 29,372 shares in multiple open-market transactions. The sales occurred across March 4–5, 2026: 7,343 shares at $43.00 ($315,749), 7,343 shares at $44.00 ($323,092), 7,343 shares at $45.00 ($330,435), and 7,343 shares at $45.50 ($334,107), for aggregate proceeds of approximately $1,303,383. These were sales (not purchases), which are often routine rather than a bullish signal.

Key Details

• Transaction dates/prices: 03/04/2026 — 7,343 sh @ $43.00; 03/05/2026 — 7,343 sh @ $44.00; 03/05/2026 — 7,343 sh @ $45.00; 03/05/2026 — 7,343 sh @ $45.50.
• Total shares sold: 29,372; total proceeds: ~$1,303,383.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Trades were made pursuant to a 10b5-1 plan adopted Nov 13, 2025 (intended to satisfy Rule 10b5-1(c) affirmative defense).
• Filing: Form 4 filed 2026-03-06; no late filing indicated based on provided dates.

Context
Sales executed under a 10b5-1 trading plan are pre-arranged and typically indicate a pre-planned disposition schedule rather than an ad hoc view on the company’s prospects. For retail investors, purchases by insiders generally carry more informational weight than planned sales; these transactions should be viewed as part of routine insider liquidity rather than a definitive signal about company performance.